CHMP turns down new indication for Lilly's duloxetine, again
18 November 2011
Francesca Bruce
Please Login to read the full article.
18 November 2011
Francesca Bruce
Please Login to read the full article.
RELATED CONTENT
NEWS
- AMT suspends Glybera and plans 50% job cuts in restructuring moves
- EU reprieve for Actos as CHMP concludes benefits outweigh risks in selected patients
- CHMP says yes to Novartis's Jakavi, BMS/AZ's Forxiga and Takeda's Rienso
- US FDA panel: Let anti-NGF studies move forward, despite 'severe' joint risks
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
